hiv-aids

Documents about hiv-aids

• HIV Viral Load Monitoring in Resource-Poor Settings#860503ClinicalTrials.gov
• Altretamine and Etoposide in Treating Patients With HIV-Related Cancer#804164ClinicalTrials.gov
• Diethylhomospermine (DEHSPM) for Refractory AIDS-Related Diarrhea#860376ClinicalTrials.gov
• Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)#918096ClinicalTrials.gov
• Histórias da Queerentena : Relatos e Elaborações de um (Outro) Isolamento Social#187876Repositório Institucional da UnB
• Prevent TB: Choice Architecture for TPT Delivery#877280ClinicalTrials.gov
• Pathways to Cardiovascular Disease Prevention (DCRI Central and Statistical Coordinating Center)#913040ClinicalTrials.gov
• Ethical and human rights implications of strategies to halt the spread of HIV/AIDs#956311SU+ Digital Repository
• The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs#891762ClinicalTrials.gov
• A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects#806023ClinicalTrials.gov
• 22 U.S.C. § 2151b-2 — Assistance to combat HIV/AIDS#579581US Code (LII)
• 25 U.S.C. § 1680v — Director of HIV/AIDS Prevention and Treatment#582387US Code (LII)
• 42 U.S.C. § 300ff-87a — National HIV/AIDS testing goal#594633US Code (LII)
• A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC)#813485ClinicalTrials.gov
• A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT)#843396ClinicalTrials.gov
• Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452#1030686ClinicalTrials.gov
• Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults#801984ClinicalTrials.gov
• Durability of Adherence in Self-Management of HIV#857464ClinicalTrials.gov
• Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania#869511ClinicalTrials.gov
• Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV#875725ClinicalTrials.gov
• WeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP)#1010585ClinicalTrials.gov
• Comparative evaluation of HIV testing interventions for men who have sex with men in the Netherlands: insights for a low-incidence setting#13877bioRxiv / medRxiv
• Comparative 48-Week Viral Load Suppression across Antiretroviral Initiation Regimens: Dolutegravir versus Non-Dolutegravir among People Living with HIV in Tanzania#67992bioRxiv / medRxiv
• Integrated Hypertension and Diabetes Mellitus Type II Treatment and Care Among People Living With HIV/AIDS#154784ClinicalTrials.gov
• Household energy poverty and sleep disorders among people living with HIV: Does the level of physical activity have any moderating effect?#610886bioRxiv / medRxiv
• Trauma Informed Prevention for Substance Use and Risky Sex#802935ClinicalTrials.gov
• A Pilot Study to Characterize the Pharmacokinetics of Raltegravir in the Cervicovaginal Fluids of HIV-infected Women#812205ClinicalTrials.gov
• Bitherapy With the Combination of Raltegravir and Darunavir (BIRDi)#826732ClinicalTrials.gov
• Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK#835217ClinicalTrials.gov
• Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV#846385ClinicalTrials.gov
• Pulmonary Complications of HIV Infection Study (PACS)#877455ClinicalTrials.gov
• Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women#889913ClinicalTrials.gov
• Development of targeted strategies to enhance linkage and retention in HIV care among people living with HIV/AIDS in Mpumalanga province.#988783NCBI PubMed Central
• Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma#995634ClinicalTrials.gov
• Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome#848603ClinicalTrials.gov
• HIV-1 Peptide Immunisation of Individuals in West Africa to Prevent Disease#471497ClinicalTrials.gov
• Christology and HIV/AIDS in Nigeria: A Theological Response to Stigma, Suffering and Human Dignity#692075PhilArchive
• Pre-exposure Prophylaxis (PrEP) at Home#858948ClinicalTrials.gov
• Pediatric Decentralization of ART in South Africa#861072ClinicalTrials.gov
• Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART)#861173ClinicalTrials.gov
• The TracTOR (Tracking and Tracing Operations Research) Study -- Zimbabwe#867117ClinicalTrials.gov
• Feasibility of SBIRT-PN#873487ClinicalTrials.gov
• SSAT058: Atripla to Eviplera Switch in Patients Without Central Nervous System Symptoms#879446ClinicalTrials.gov
• The Intensified Treatment Monitoring Strategy to Prevent Accumulation of Drug Resistance (ITREMA) Trial#900066ClinicalTrials.gov
• A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules#836046ClinicalTrials.gov
• AIDS prevention : guidelines for MCH/FP programme managers. II. AIDS and maternal and child health#466861WHO IRIS
• 22 U.S.C. § 6812 — African crisis response initiative and HIV/AIDS training#578145US Code (LII)
• An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS (Project Legacy)#898558ClinicalTrials.gov
• Taking Informed Consent Seriously in Global HIV Vaccine Research#169551Scholarly Commons at Boston University School of Law
• iSTEP - an mHealth Physical Activity and Diet Intervention for Persons With HIV#868699ClinicalTrials.gov